About RenagelRenagel controls serum phosphorus in patients with CKD hemodialysis.

About RenagelRenagel controls serum phosphorus in patients with CKD hemodialysis. Controlling serum phosphorus is an important element in the care of hemodialysis patients. Inhorus levels are common in dialysis patients and associated with increased risk for cardiovascular mortality. Renagel offers the additional advantage of the significant reduction in LDL cholesterol . Genzyme and Renagel are registered trademarks and Renvela is a trademark of Genzyme Corporation. All rights reserved.

Genzyme Corp. announced today that a recently completed study of Renvela met its primary endpoint, which is statistically significant reduction in serum phosphorus hyperphosphatemic for patients with chronic kidney disease, dialysis, no.A new test that on cancer would at the horizon, according to one study at British Journal of Cancer* present published.

‘We are now looking tumor tumor M2-PK in a major study, however of this enzyme has the potential to be an outstanding assurance net. It could be be seen longer cases of the disease and potentially unnecessary medical procedure with fewer false-positive results ‘.

Other entries from category "pregnancy":

Random entries